Skip to content

Withings Study to Analyse the Accuracy of Screening Small Fiver Neuropathy With a Bathroom Scale

Withings Study to Analyse the Accuracy of Screening Small Fiver Neuropathy With a Bathroom Scale

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05178459
Acronym
WISUDO
Enrollment
177
Registered
2022-01-05
Start date
2022-03-11
Completion date
2022-08-08
Last updated
2023-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuropathy

Brief summary

The aim of this study is to evaluate the diagnostic performance of Withings WBS08 to screen small fiber neuropathy.

Detailed description

Patients with neuropathy are included in hospitals. Each patient will have his neuropathy evaluated with Withings WBS08 and its reference the Sudoscan.

Interventions

DIAGNOSTIC_TESTNeuropathy measurement

Patient will step on Withings WBS08 and on the Sudoscan to get their sudomotor dysfunction caused by the neuropathy evaluated.

Sponsors

Withings
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The subject is an adult, man or woman (18 years old or more) * Subjects affiliated or eligible to a social security system * Subjects having expressed their consent to take part in the study * Two type of patients are included in the study : * Patients having diabetes (80% of the inclusion) * Non diabetic patients having a lower limbs neuropathy (20% of the inclusion)

Exclusion criteria

* Minors under 18 years old * Subject is pregnant or trying to get pregnant * Subjects having a pacemaker * Subjects having refused to give their consent * Vulnerable subjects according to the French regulation in force: * Individuals deprived of liberty by a court, medical or administrative order * Individuals legally protected or unable to express their consent to take part in the study * Individuals unaffiliated to or not beneficiary of a social security system * Individuals who fit in multiple categories above * Individuals linguistically or mentally unable to express their consent * Individuals having an lower limb amputation bigger than toes * Individuals not able to stand still for a few minutes * Individuals under antidepressant medications

Design outcomes

Primary

MeasureTime frameDescription
Sudomotor dysfunction diagnostic performance evaluation10 monthsThe diagnostic performance of the Withings WBS08 will be established using the sensitivity and the specificity for an electrochemical skin conductance threshold (moderate dysfunction and severe dysfunction).

Secondary

MeasureTime frameDescription
Evaluate the accuracy of Withings WBS08 to measure the sudomotor function on each foot and by averaging the value on both feet.10 monthsThe root-mean-square error (RMSE) and the mean absolute error (MAE) between the sudomotor function value measured by the Withings WBS08 and the Sudoscan as reference on each foot and by averagin g both feet.
Compare the diagnostic of Withings WBS08 to diabetes neuropathy questionnaires10 monthsThe correlation between diabetes neuropathy questionnair es and Withings WBS08.
Safety use of this device10 monthsThe rate of adverse effects.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026